Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIRS Neurofeedback for ADHD in Children
NCT04065906Unknown
- Sponsor
- Xijing Hospital
- Start
- Jan 2019
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Open-label trial in attention deficit hyperactivity disorder (ADHD), sponsored by Xijing Hospital. Primary endpoint: Swanson, Nolan, and Pelham IV Scale at week 8. Status: unknown.
02
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT04065906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04065906.